We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
-16.98%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$4.68B
AUM Growth
-$1.71B
(-27%)
Cap. Flow
-$462M
Cap. Flow
% of AUM
-9.88%
Top 10 Holdings %
Top 10 Hldgs %
25.31%
Holding
149
New
16
Increased
23
Reduced
54
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Doximity
DOCS
|
+$59.6M |
| 2 |
GTM
ZoomInfo Technologies
GTM
|
+$19.8M |
| 3 |
CMS Energy
CMS
|
+$19.8M |
| 4 |
Guardant Health
GH
|
+$18.2M |
| 5 |
Cheniere Energy
LNG
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dynatrace
DT
|
+$112M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$64.6M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
+$38.2M |
| 4 |
Roper Technologies
ROP
|
+$32.9M |
| 5 |
Lam Research
LRCX
|
+$31.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.3% |
| 2 | Technology | 26.13% |
| 3 | Industrials | 16.22% |
| 4 | Consumer Discretionary | 5.49% |
| 5 | Utilities | 5.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Design Therapeutics
DSGN
$788M
| $3.94M | 0.08% |
281,569
-118,431
| -30% | -$1.6M |
|
127
Advanced Drainage Systems
WMS
$10.5B
| $3.61M | 0.08% |
40,052
-18,026
| -31% | -$1.85M |
|
128
iRhythm Holdings
IRTC
$3.91B
| $3.17M | 0.07% |
+29,300
| New | +$3.88M |
|
129
Phathom Pharmaceuticals
PHAT
$720M
| $2.84M | 0.06% |
336,223
| – | – |
|
130
Silicon Laboratories
SLAB
$7.15B
| $2.68M | 0.06% |
19,137
| – | – |
|
131
Flywire
FLYW
$2.01B
| $2.34M | 0.05% |
+132,921
| New | +$3.09M |
|
132
monday.com
MNDY
$3.73B
| $2.1M | 0.05% |
20,409
-12,091
| -37% | -$1.47M |
|
133
Ciena
CIEN
$52.7B
| $1.46M | 0.03% |
32,000
-11,000
| -26% | -$570K |
|
134
Arteris
AIP
$1.35B
| $1.38M | 0.03% |
198,509
+4,509
| +2% | +$46.2K |
|
135
KB Home
KBH
$3.45B
| $999K | 0.02% |
35,100
-106,600
| -75% | -$3.4M |
|
136
Azenta
AZTA
$1.33B
| – | – |
-29,700
| Closed | -$2.46M |
|
137
Bolt Biotherapeutics
BOLT
$7.47M
| – | – |
-42,991
| Closed | -$2.36M |
|
138
Cullinan Oncology
CGEM
$1.08B
| – | – |
-1,440,145
| Closed | -$15.1M |
|
139
Cardiff Oncology
CRDF
$66.2M
| – | – |
-1,467,922
| Closed | -$3.64M |
|
|
140
Dynatrace
DT
$12.8B
| – | – |
-2,386,741
| Closed | -$112M |
|
141
Shift4
FOUR
$4.26B
| – | – |
-70,000
| Closed | -$4.33M |
|
142
nCino
NCNO
$2.01B
| – | – |
-416,200
| Closed | -$17.1M |
|
143
Outset Medical
OM
$88.1M
| – | – |
-4,600
| Closed | -$3.13M |
|
144
Syndax Pharmaceuticals
SNDX
$1.73B
| – | – |
-1,165,000
| Closed | -$20.2M |
|
145
Xencor
XNCR
$1.59B
| – | – |
-500,755
| Closed | -$13.4M |
|
|
SMAR
146
DELISTED
Smartsheet Inc.
SMAR
| – | – |
-697,000
| Closed | -$38.2M |
|
|
IMGN
147
DELISTED
Immunogen Inc
IMGN
| – | – |
-1,000,000
| Closed | -$4.76M |
|
|
ETTX
148
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| – | – |
-590,602
| Closed | -$1.1M |
|
Similar funds
HPG
EMPI
RCG
JWBC
AAM
AA
CM
CIS
Eventide Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Eventide Asset Management held 149 positions worth $4.68B, down 27% from $6.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Eventide Asset Management withdrew a net $462M in Q2 2022, closing 13 positions and reducing 54 holdings. Its most notable exit was Dynatrace, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Eventide Asset Management opened a new position in Doximity worth $52.7M.
- Eventide Asset Management's largest Q2 2022 buy was Doximity: 1,512,602 shares worth $52.7M.
- Eventide Asset Management added most to ZoomInfo Technologies in Q2 2022, an estimated $19.8M increase.
- Eventide Asset Management's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $64.6M.
- Eventide Asset Management fully exited Dynatrace in Q2 2022, selling an estimated $112M.
- Eventide Asset Management's ten largest holdings make up 25% of its $4.68B portfolio in Q2 2022.
- Eventide Asset Management opened 16 new positions and closed 13 in Q2 2022.
- Eventide Asset Management's portfolio value fell 27% quarter-over-quarter to $4.68B.
Based on Eventide Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.